LOW vs NEPH · P/E 18, rev $86.29B vs P/E 48, rev $14.2M
Lowe's Companies Inc (LOW) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the LOW and NEPH stock pages for the full models.
Not investment advice.